Table of Content

1 Study Coverage
1.1 Gefitinib Tablets Product Introduction
1.2 Market by Type
1.2.1 Global Gefitinib Tablets Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Gefitinib Tablets Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gefitinib Tablets Sales Estimates and Forecasts 2024-2034
2.2 Global Gefitinib Tablets Revenue by Region
2.2.1 Global Gefitinib Tablets Revenue by Region: 2024 VS 2022 VS 2034
2.2.2 Global Gefitinib Tablets Revenue by Region (2024-2024)
2.2.3 Global Gefitinib Tablets Revenue by Region (2024-2034)
2.2.4 Global Gefitinib Tablets Revenue Market Share by Region (2024-2034)
2.3 Global Gefitinib Tablets Sales Estimates and Forecasts 2024-2034
2.4 Global Gefitinib Tablets Sales by Region
2.4.1 Global Gefitinib Tablets Sales by Region: 2024 VS 2022 VS 2034
2.4.2 Global Gefitinib Tablets Sales by Region (2024-2024)
2.4.3 Global Gefitinib Tablets Sales by Region (2024-2034)
2.4.4 Global Gefitinib Tablets Sales Market Share by Region (2024-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Gefitinib Tablets Sales by Manufacturers
3.1.1 Global Gefitinib Tablets Sales by Manufacturers (2024-2024)
3.1.2 Global Gefitinib Tablets Sales Market Share by Manufacturers (2024-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gefitinib Tablets in 2022
3.2 Global Gefitinib Tablets Revenue by Manufacturers
3.2.1 Global Gefitinib Tablets Revenue by Manufacturers (2024-2024)
3.2.2 Global Gefitinib Tablets Revenue Market Share by Manufacturers (2024-2024)
3.2.3 Global Top 10 and Top 5 Companies by Gefitinib Tablets Revenue in 2022
3.3 Global Key Players of Gefitinib Tablets, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Gefitinib Tablets Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gefitinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gefitinib Tablets, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gefitinib Tablets, Product Offered and Application
3.8 Global Key Manufacturers of Gefitinib Tablets, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gefitinib Tablets Sales by Type
4.1.1 Global Gefitinib Tablets Historical Sales by Type (2024-2024)
4.1.2 Global Gefitinib Tablets Forecasted Sales by Type (2024-2034)
4.1.3 Global Gefitinib Tablets Sales Market Share by Type (2024-2034)
4.2 Global Gefitinib Tablets Revenue by Type
4.2.1 Global Gefitinib Tablets Historical Revenue by Type (2024-2024)
4.2.2 Global Gefitinib Tablets Forecasted Revenue by Type (2024-2034)
4.2.3 Global Gefitinib Tablets Revenue Market Share by Type (2024-2034)
4.3 Global Gefitinib Tablets Price by Type
4.3.1 Global Gefitinib Tablets Price by Type (2024-2024)
4.3.2 Global Gefitinib Tablets Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Gefitinib Tablets Sales by Application
5.1.1 Global Gefitinib Tablets Historical Sales by Application (2024-2024)
5.1.2 Global Gefitinib Tablets Forecasted Sales by Application (2024-2034)
5.1.3 Global Gefitinib Tablets Sales Market Share by Application (2024-2034)
5.2 Global Gefitinib Tablets Revenue by Application
5.2.1 Global Gefitinib Tablets Historical Revenue by Application (2024-2024)
5.2.2 Global Gefitinib Tablets Forecasted Revenue by Application (2024-2034)
5.2.3 Global Gefitinib Tablets Revenue Market Share by Application (2024-2034)
5.3 Global Gefitinib Tablets Price by Application
5.3.1 Global Gefitinib Tablets Price by Application (2024-2024)
5.3.2 Global Gefitinib Tablets Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Gefitinib Tablets Market Size by Type
6.1.1 US & Canada Gefitinib Tablets Sales by Type (2024-2034)
6.1.2 US & Canada Gefitinib Tablets Revenue by Type (2024-2034)
6.2 US & Canada Gefitinib Tablets Market Size by Application
6.2.1 US & Canada Gefitinib Tablets Sales by Application (2024-2034)
6.2.2 US & Canada Gefitinib Tablets Revenue by Application (2024-2034)
6.3 US & Canada Gefitinib Tablets Market Size by Country
6.3.1 US & Canada Gefitinib Tablets Revenue by Country: 2024 VS 2022 VS 2034
6.3.2 US & Canada Gefitinib Tablets Sales by Country (2024-2034)
6.3.3 US & Canada Gefitinib Tablets Revenue by Country (2024-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Gefitinib Tablets Market Size by Type
7.1.1 Europe Gefitinib Tablets Sales by Type (2024-2034)
7.1.2 Europe Gefitinib Tablets Revenue by Type (2024-2034)
7.2 Europe Gefitinib Tablets Market Size by Application
7.2.1 Europe Gefitinib Tablets Sales by Application (2024-2034)
7.2.2 Europe Gefitinib Tablets Revenue by Application (2024-2034)
7.3 Europe Gefitinib Tablets Market Size by Country
7.3.1 Europe Gefitinib Tablets Revenue by Country: 2024 VS 2022 VS 2034
7.3.2 Europe Gefitinib Tablets Sales by Country (2024-2034)
7.3.3 Europe Gefitinib Tablets Revenue by Country (2024-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Gefitinib Tablets Market Size
8.1.1 China Gefitinib Tablets Sales (2024-2034)
8.1.2 China Gefitinib Tablets Revenue (2024-2034)
8.2 China Gefitinib Tablets Market Size by Application
8.2.1 China Gefitinib Tablets Sales by Application (2024-2034)
8.2.2 China Gefitinib Tablets Revenue by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Gefitinib Tablets Market Size by Type
9.1.1 Asia Gefitinib Tablets Sales by Type (2024-2034)
9.1.2 Asia Gefitinib Tablets Revenue by Type (2024-2034)
9.2 Asia Gefitinib Tablets Market Size by Application
9.2.1 Asia Gefitinib Tablets Sales by Application (2024-2034)
9.2.2 Asia Gefitinib Tablets Revenue by Application (2024-2034)
9.3 Asia Gefitinib Tablets Sales by Region
9.3.1 Asia Gefitinib Tablets Revenue by Region: 2024 VS 2022 VS 2034
9.3.2 Asia Gefitinib Tablets Revenue by Region (2024-2034)
9.3.3 Asia Gefitinib Tablets Sales by Region (2024-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gefitinib Tablets Market Size by Type
10.1.1 Middle East, Africa and Latin America Gefitinib Tablets Sales by Type (2024-2034)
10.1.2 Middle East, Africa and Latin America Gefitinib Tablets Revenue by Type (2024-2034)
10.2 Middle East, Africa and Latin America Gefitinib Tablets Market Size by Application
10.2.1 Middle East, Africa and Latin America Gefitinib Tablets Sales by Application (2024-2034)
10.2.2 Middle East, Africa and Latin America Gefitinib Tablets Revenue by Application (2024-2034)
10.3 Middle East, Africa and Latin America Gefitinib Tablets Sales by Country
10.3.1 Middle East, Africa and Latin America Gefitinib Tablets Revenue by Country: 2024 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Gefitinib Tablets Revenue by Country (2024-2034)
10.3.3 Middle East, Africa and Latin America Gefitinib Tablets Sales by Country (2024-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Information
11.1.2 Qilu Pharmaceutical Overview
11.1.3 Qilu Pharmaceutical Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.1.4 Qilu Pharmaceutical Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Qilu Pharmaceutical Recent Developments
11.2 Sichuan Kelun Pharmaceutical Co.,Ltd.
11.2.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
11.2.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Overview
11.2.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.2.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments
11.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
11.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
11.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Overview
11.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments
11.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
11.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
11.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Overview
11.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments
11.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
11.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
11.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Overview
11.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments
11.6 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
11.6.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
11.6.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Overview
11.6.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.6.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments
11.7 Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
11.7.1 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
11.7.2 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Overview
11.7.3 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.7.4 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Recent Developments
11.8 NatcoPharma
11.8.1 NatcoPharma Company Information
11.8.2 NatcoPharma Overview
11.8.3 NatcoPharma Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.8.4 NatcoPharma Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 NatcoPharma Recent Developments
11.9 AstraZeneca plc
11.9.1 AstraZeneca plc Company Information
11.9.2 AstraZeneca plc Overview
11.9.3 AstraZeneca plc Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.9.4 AstraZeneca plc Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca plc Recent Developments
11.10 Intelicure Lifesciences
11.10.1 Intelicure Lifesciences Company Information
11.10.2 Intelicure Lifesciences Overview
11.10.3 Intelicure Lifesciences Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.10.4 Intelicure Lifesciences Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Intelicure Lifesciences Recent Developments
11.11 Weefsel Pharma
11.11.1 Weefsel Pharma Company Information
11.11.2 Weefsel Pharma Overview
11.11.3 Weefsel Pharma Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.11.4 Weefsel Pharma Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Weefsel Pharma Recent Developments
11.12 Taj Pharmaceuticals
11.12.1 Taj Pharmaceuticals Company Information
11.12.2 Taj Pharmaceuticals Overview
11.12.3 Taj Pharmaceuticals Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.12.4 Taj Pharmaceuticals Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Taj Pharmaceuticals Recent Developments
11.13 Saintroy Lifescience
11.13.1 Saintroy Lifescience Company Information
11.13.2 Saintroy Lifescience Overview
11.13.3 Saintroy Lifescience Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.13.4 Saintroy Lifescience Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Saintroy Lifescience Recent Developments
11.14 Actiza Pharmaceutical
11.14.1 Actiza Pharmaceutical Company Information
11.14.2 Actiza Pharmaceutical Overview
11.14.3 Actiza Pharmaceutical Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.14.4 Actiza Pharmaceutical Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Actiza Pharmaceutical Recent Developments
11.15 Teva
11.15.1 Teva Company Information
11.15.2 Teva Overview
11.15.3 Teva Gefitinib Tablets Sales, Price, Revenue and Gross Margin (2024-2024)
11.15.4 Teva Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Teva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gefitinib Tablets Industry Chain Analysis
12.2 Gefitinib Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gefitinib Tablets Production Mode & Process
12.4 Gefitinib Tablets Sales and Marketing
12.4.1 Gefitinib Tablets Sales Channels
12.4.2 Gefitinib Tablets Distributors
12.5 Gefitinib Tablets Customers
13 Market Dynamics
13.1 Gefitinib Tablets Industry Trends
13.2 Gefitinib Tablets Market Drivers
13.3 Gefitinib Tablets Market Challenges
13.4 Gefitinib Tablets Market Restraints
14 Key Findings in The Global Gefitinib Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gefitinib Tablets Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Original Drugs
Table 3. Major Manufacturers of Generic Drugs
Table 4. Global Gefitinib Tablets Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Gefitinib Tablets Revenue Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Gefitinib Tablets Revenue by Region (2024-2024) & (US$ Million)
Table 7. Global Gefitinib Tablets Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Gefitinib Tablets Revenue Market Share by Region (2024-2024)
Table 9. Global Gefitinib Tablets Revenue Market Share by Region (2024-2034)
Table 10. Global Gefitinib Tablets Sales Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 11. Global Gefitinib Tablets Sales by Region (2024-2024) & (K Units)
Table 12. Global Gefitinib Tablets Sales by Region (2024-2034) & (K Units)
Table 13. Global Gefitinib Tablets Sales Market Share by Region (2024-2024)
Table 14. Global Gefitinib Tablets Sales Market Share by Region (2024-2034)
Table 15. Global Gefitinib Tablets Sales by Manufacturers (2024-2024) & (K Units)
Table 16. Global Gefitinib Tablets Sales Share by Manufacturers (2024-2024)
Table 17. Global Gefitinib Tablets Revenue by Manufacturers (2024-2024) & (US$ Million)
Table 18. Global Gefitinib Tablets Revenue Share by Manufacturers (2024-2024)
Table 19. Global Key Players of Gefitinib Tablets, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Gefitinib Tablets Price by Manufacturers 2024-2024 (US$/Unit)
Table 21. Global Gefitinib Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Gefitinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gefitinib Tablets as of 2022)
Table 23. Global Key Manufacturers of Gefitinib Tablets, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Gefitinib Tablets, Product Offered and Application
Table 25. Global Key Manufacturers of Gefitinib Tablets, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gefitinib Tablets Sales by Type (2024-2024) & (K Units)
Table 28. Global Gefitinib Tablets Sales by Type (2024-2034) & (K Units)
Table 29. Global Gefitinib Tablets Sales Share by Type (2024-2024)
Table 30. Global Gefitinib Tablets Sales Share by Type (2024-2034)
Table 31. Global Gefitinib Tablets Revenue by Type (2024-2024) & (US$ Million)
Table 32. Global Gefitinib Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Gefitinib Tablets Revenue Share by Type (2024-2024)
Table 34. Global Gefitinib Tablets Revenue Share by Type (2024-2034)
Table 35. Gefitinib Tablets Price by Type (2024-2024) & (US$/Unit)
Table 36. Global Gefitinib Tablets Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Gefitinib Tablets Sales by Application (2024-2024) & (K Units)
Table 38. Global Gefitinib Tablets Sales by Application (2024-2034) & (K Units)
Table 39. Global Gefitinib Tablets Sales Share by Application (2024-2024)
Table 40. Global Gefitinib Tablets Sales Share by Application (2024-2034)
Table 41. Global Gefitinib Tablets Revenue by Application (2024-2024) & (US$ Million)
Table 42. Global Gefitinib Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Gefitinib Tablets Revenue Share by Application (2024-2024)
Table 44. Global Gefitinib Tablets Revenue Share by Application (2024-2034)
Table 45. Gefitinib Tablets Price by Application (2024-2024) & (US$/Unit)
Table 46. Global Gefitinib Tablets Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Gefitinib Tablets Sales by Type (2024-2024) & (K Units)
Table 48. US & Canada Gefitinib Tablets Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Gefitinib Tablets Revenue by Type (2024-2024) & (US$ Million)
Table 50. US & Canada Gefitinib Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Gefitinib Tablets Sales by Application (2024-2024) & (K Units)
Table 52. US & Canada Gefitinib Tablets Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Gefitinib Tablets Revenue by Application (2024-2024) & (US$ Million)
Table 54. US & Canada Gefitinib Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Gefitinib Tablets Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Gefitinib Tablets Revenue by Country (2024-2024) & (US$ Million)
Table 57. US & Canada Gefitinib Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Gefitinib Tablets Sales by Country (2024-2024) & (K Units)
Table 59. US & Canada Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 60. Europe Gefitinib Tablets Sales by Type (2024-2024) & (K Units)
Table 61. Europe Gefitinib Tablets Sales by Type (2024-2034) & (K Units)
Table 62. Europe Gefitinib Tablets Revenue by Type (2024-2024) & (US$ Million)
Table 63. Europe Gefitinib Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Gefitinib Tablets Sales by Application (2024-2024) & (K Units)
Table 65. Europe Gefitinib Tablets Sales by Application (2024-2034) & (K Units)
Table 66. Europe Gefitinib Tablets Revenue by Application (2024-2024) & (US$ Million)
Table 67. Europe Gefitinib Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Gefitinib Tablets Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Gefitinib Tablets Revenue by Country (2024-2024) & (US$ Million)
Table 70. Europe Gefitinib Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Gefitinib Tablets Sales by Country (2024-2024) & (K Units)
Table 72. Europe Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 73. China Gefitinib Tablets Sales by Type (2024-2024) & (K Units)
Table 74. China Gefitinib Tablets Sales by Type (2024-2034) & (K Units)
Table 75. China Gefitinib Tablets Revenue by Type (2024-2024) & (US$ Million)
Table 76. China Gefitinib Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Gefitinib Tablets Sales by Application (2024-2024) & (K Units)
Table 78. China Gefitinib Tablets Sales by Application (2024-2034) & (K Units)
Table 79. China Gefitinib Tablets Revenue by Application (2024-2024) & (US$ Million)
Table 80. China Gefitinib Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Gefitinib Tablets Sales by Type (2024-2024) & (K Units)
Table 82. Asia Gefitinib Tablets Sales by Type (2024-2034) & (K Units)
Table 83. Asia Gefitinib Tablets Revenue by Type (2024-2024) & (US$ Million)
Table 84. Asia Gefitinib Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Gefitinib Tablets Sales by Application (2024-2024) & (K Units)
Table 86. Asia Gefitinib Tablets Sales by Application (2024-2034) & (K Units)
Table 87. Asia Gefitinib Tablets Revenue by Application (2024-2024) & (US$ Million)
Table 88. Asia Gefitinib Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Gefitinib Tablets Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Gefitinib Tablets Revenue by Region (2024-2024) & (US$ Million)
Table 91. Asia Gefitinib Tablets Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Gefitinib Tablets Sales by Region (2024-2024) & (K Units)
Table 93. Asia Gefitinib Tablets Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Gefitinib Tablets Sales by Type (2024-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Gefitinib Tablets Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Gefitinib Tablets Revenue by Type (2024-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Gefitinib Tablets Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Gefitinib Tablets Sales by Application (2024-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Gefitinib Tablets Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Gefitinib Tablets Revenue by Application (2024-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Gefitinib Tablets Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Gefitinib Tablets Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Gefitinib Tablets Revenue by Country (2024-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Gefitinib Tablets Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Gefitinib Tablets Sales by Country (2024-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Gefitinib Tablets Sales by Country (2024-2034) & (K Units)
Table 107. Qilu Pharmaceutical Company Information
Table 108. Qilu Pharmaceutical Description and Major Businesses
Table 109. Qilu Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Qilu Pharmaceutical Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Qilu Pharmaceutical Recent Developments
Table 112. Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
Table 113. Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Major Businesses
Table 114. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments
Table 117. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 118. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Major Businesses
Table 119. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments
Table 122. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
Table 123. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Major Businesses
Table 124. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments
Table 127. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 128. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Major Businesses
Table 129. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments
Table 132. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
Table 133. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Description and Major Businesses
Table 134. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments
Table 137. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
Table 138. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Description and Major Businesses
Table 139. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Recent Developments
Table 142. NatcoPharma Company Information
Table 143. NatcoPharma Description and Major Businesses
Table 144. NatcoPharma Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. NatcoPharma Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. NatcoPharma Recent Developments
Table 147. AstraZeneca plc Company Information
Table 148. AstraZeneca plc Description and Major Businesses
Table 149. AstraZeneca plc Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. AstraZeneca plc Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. AstraZeneca plc Recent Developments
Table 152. Intelicure Lifesciences Company Information
Table 153. Intelicure Lifesciences Description and Major Businesses
Table 154. Intelicure Lifesciences Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Intelicure Lifesciences Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Intelicure Lifesciences Recent Developments
Table 157. Weefsel Pharma Company Information
Table 158. Weefsel Pharma Description and Major Businesses
Table 159. Weefsel Pharma Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Weefsel Pharma Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Weefsel Pharma Recent Developments
Table 162. Taj Pharmaceuticals Company Information
Table 163. Taj Pharmaceuticals Description and Major Businesses
Table 164. Taj Pharmaceuticals Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Taj Pharmaceuticals Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Taj Pharmaceuticals Recent Developments
Table 167. Saintroy Lifescience Company Information
Table 168. Saintroy Lifescience Description and Major Businesses
Table 169. Saintroy Lifescience Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Saintroy Lifescience Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Saintroy Lifescience Recent Developments
Table 172. Actiza Pharmaceutical Company Information
Table 173. Actiza Pharmaceutical Description and Major Businesses
Table 174. Actiza Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Actiza Pharmaceutical Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Actiza Pharmaceutical Recent Developments
Table 177. Teva Company Information
Table 178. Teva Description and Major Businesses
Table 179. Teva Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Teva Gefitinib Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Teva Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Gefitinib Tablets Distributors List
Table 185. Gefitinib Tablets Customers List
Table 186. Gefitinib Tablets Market Trends
Table 187. Gefitinib Tablets Market Drivers
Table 188. Gefitinib Tablets Market Challenges
Table 189. Gefitinib Tablets Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Gefitinib Tablets Product Picture
Figure 2. Global Gefitinib Tablets Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Gefitinib Tablets Market Share by Type in 2022 & 2034
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Gefitinib Tablets Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Gefitinib Tablets Market Share by Application in 2022 & 2034
Figure 8. Breast Cancer
Figure 9. Lung Cancer
Figure 10. Other
Figure 11. Gefitinib Tablets Report Years Considered
Figure 12. Global Gefitinib Tablets Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Gefitinib Tablets Revenue 2024-2034 (US$ Million)
Figure 14. Global Gefitinib Tablets Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Gefitinib Tablets Revenue Market Share by Region (2024-2034)
Figure 16. Global Gefitinib Tablets Sales 2024-2034 ((K Units)
Figure 17. Global Gefitinib Tablets Sales Market Share by Region (2024-2034)
Figure 18. US & Canada Gefitinib Tablets Sales YoY (2024-2034) & (K Units)
Figure 19. US & Canada Gefitinib Tablets Revenue YoY (2024-2034) & (US$ Million)
Figure 20. Europe Gefitinib Tablets Sales YoY (2024-2034) & (K Units)
Figure 21. Europe Gefitinib Tablets Revenue YoY (2024-2034) & (US$ Million)
Figure 22. China Gefitinib Tablets Sales YoY (2024-2034) & (K Units)
Figure 23. China Gefitinib Tablets Revenue YoY (2024-2034) & (US$ Million)
Figure 24. Asia (excluding China) Gefitinib Tablets Sales YoY (2024-2034) & (K Units)
Figure 25. Asia (excluding China) Gefitinib Tablets Revenue YoY (2024-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Gefitinib Tablets Sales YoY (2024-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Gefitinib Tablets Revenue YoY (2024-2034) & (US$ Million)
Figure 28. The Gefitinib Tablets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Gefitinib Tablets in the World: Market Share by Gefitinib Tablets Revenue in 2022
Figure 30. Global Gefitinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 31. Global Gefitinib Tablets Sales Market Share by Type (2024-2034)
Figure 32. Global Gefitinib Tablets Revenue Market Share by Type (2024-2034)
Figure 33. Global Gefitinib Tablets Sales Market Share by Application (2024-2034)
Figure 34. Global Gefitinib Tablets Revenue Market Share by Application (2024-2034)
Figure 35. US & Canada Gefitinib Tablets Sales Market Share by Type (2024-2034)
Figure 36. US & Canada Gefitinib Tablets Revenue Market Share by Type (2024-2034)
Figure 37. US & Canada Gefitinib Tablets Sales Market Share by Application (2024-2034)
Figure 38. US & Canada Gefitinib Tablets Revenue Market Share by Application (2024-2034)
Figure 39. US & Canada Gefitinib Tablets Revenue Share by Country (2024-2034)
Figure 40. US & Canada Gefitinib Tablets Sales Share by Country (2024-2034)
Figure 41. U.S. Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 42. Canada Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 43. Europe Gefitinib Tablets Sales Market Share by Type (2024-2034)
Figure 44. Europe Gefitinib Tablets Revenue Market Share by Type (2024-2034)
Figure 45. Europe Gefitinib Tablets Sales Market Share by Application (2024-2034)
Figure 46. Europe Gefitinib Tablets Revenue Market Share by Application (2024-2034)
Figure 47. Europe Gefitinib Tablets Revenue Share by Country (2024-2034)
Figure 48. Europe Gefitinib Tablets Sales Share by Country (2024-2034)
Figure 49. Germany Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 50. France Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 51. U.K. Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 52. Italy Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 53. Russia Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 54. China Gefitinib Tablets Sales Market Share by Type (2024-2034)
Figure 55. China Gefitinib Tablets Revenue Market Share by Type (2024-2034)
Figure 56. China Gefitinib Tablets Sales Market Share by Application (2024-2034)
Figure 57. China Gefitinib Tablets Revenue Market Share by Application (2024-2034)
Figure 58. Asia Gefitinib Tablets Sales Market Share by Type (2024-2034)
Figure 59. Asia Gefitinib Tablets Revenue Market Share by Type (2024-2034)
Figure 60. Asia Gefitinib Tablets Sales Market Share by Application (2024-2034)
Figure 61. Asia Gefitinib Tablets Revenue Market Share by Application (2024-2034)
Figure 62. Asia Gefitinib Tablets Revenue Share by Region (2024-2034)
Figure 63. Asia Gefitinib Tablets Sales Share by Region (2024-2034)
Figure 64. Japan Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 65. South Korea Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 66. China Taiwan Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 67. Southeast Asia Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 68. India Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Gefitinib Tablets Sales Market Share by Type (2024-2034)
Figure 70. Middle East, Africa and Latin America Gefitinib Tablets Revenue Market Share by Type (2024-2034)
Figure 71. Middle East, Africa and Latin America Gefitinib Tablets Sales Market Share by Application (2024-2034)
Figure 72. Middle East, Africa and Latin America Gefitinib Tablets Revenue Market Share by Application (2024-2034)
Figure 73. Middle East, Africa and Latin America Gefitinib Tablets Revenue Share by Country (2024-2034)
Figure 74. Middle East, Africa and Latin America Gefitinib Tablets Sales Share by Country (2024-2034)
Figure 75. Brazil Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 76. Mexico Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 77. Turkey Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 78. Israel Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 79. GCC Countries Gefitinib Tablets Revenue (2024-2034) & (US$ Million)
Figure 80. Gefitinib Tablets Value Chain
Figure 81. Gefitinib Tablets Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed